Fresenius Kabi USA, LLC recalls Xylocaine (lidocaine HCl Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of Particulate Matter: Hair was found in products
- Products
-
- Xylocaine (lidocaine HCl Injection
- Company
- Fresenius Kabi USA, LLC
- Where it was sold
-
Nationwide within in the USA
Nationwide
- Units affected
- 93,250 vials
- About this recall
- Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01